Acadian Asset Management
ACHN

Acadian Asset Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Acadian Asset Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15,914
Closed -$57K – 2171
2019
Q3 		$57K Hold
15,914
– – ﹤0.01% 1588
2019
Q2 		$43K Sell
15,914
-262,659
-94% -$776K ﹤0.01% 1503
2019
Q1 		$825K Buy
278,573
+252,613
+973% +$621K ﹤0.01% 960
2018
Q4 		$41K Buy
+25,960
New +$73.4K ﹤0.01% 1457
2018
Q3 		– Sell
-47,670
Closed -$135K – 1864
2018
Q2 		$135K Sell
47,670
-34,808
-42% -$119K ﹤0.01% 1173
2018
Q1 		$306K Buy
+82,478
New +$270K ﹤0.01% 970

Other funds holding ACHN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management's ACHN Position: Q4 2019 in Review

Acadian Asset Management sold out of Achillion Pharmaceuticals (ACHN) in Q4 2019, closing a stake of 15,914 shares — an estimated $57K sold.

Acadian Asset Management first reported a position in ACHN in Q1 2018 and held it in 6 quarters. The position peaked at $825K in Q1 2019. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

  • Acadian Asset Management reported no remaining Achillion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Acadian Asset Management sold 15,914 Achillion Pharmaceuticals shares in Q4 2019, an estimated $57K.
  • Acadian Asset Management first reported a position in Achillion Pharmaceuticals in Q1 2018 and held it in 6 quarters.
  • Acadian Asset Management's Achillion Pharmaceuticals position peaked at $825K in Q1 2019.
  • 132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on Acadian Asset Management's 13F filing for Q4 2019, filed 6 Feb 2020.